Cargando…

Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens

Infectious bronchitis (IB) is a highly contagious upper respiratory tract disease of chickens caused by infectious bronchitis virus (IBV), which has various serotypes that do not cross-protect. Vaccine control strategies for this virus are only effective when designed around the currently circulatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Jongseo, Angelichio, Michael, Gow, Lisa, Leathers, Valerie, Jackwood, Mark W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113781/
https://www.ncbi.nlm.nih.gov/pubmed/31712094
http://dx.doi.org/10.1016/j.jviromet.2019.113773
_version_ 1783513746125094912
author Mo, Jongseo
Angelichio, Michael
Gow, Lisa
Leathers, Valerie
Jackwood, Mark W.
author_facet Mo, Jongseo
Angelichio, Michael
Gow, Lisa
Leathers, Valerie
Jackwood, Mark W.
author_sort Mo, Jongseo
collection PubMed
description Infectious bronchitis (IB) is a highly contagious upper respiratory tract disease of chickens caused by infectious bronchitis virus (IBV), which has various serotypes that do not cross-protect. Vaccine control strategies for this virus are only effective when designed around the currently circulating serotypes. It is essential to not only rapidly detect IBV but also to identify the type of virus causing disease. Six TaqMan™-based quantitative real-time RT-PCR assays (Universal, Ark, Mass, DE/GA98, GA07, GA08) were developed and examined the sensitivity and specificity for each assay. Assays were developed targeting the hypervariable region in the S1 gene subunit. The analytical sensitivity of TaqMan™-based quantitative real-time RT-PCR assays (qRT-PCR) assays was evaluated using synthetic DNA standards that were identical with the target sequence and specificity was further validated using clinical and biological specimens. All developed assays performed equivalently when using synthetic DNA templates as standard material, as it achieved linearity over a 5 log(10) dynamic range with a reproducible limit of detection of ≤10 target copies per reaction, with high calculated amplification efficiencies ranging between 90%–115%. Further validation of specificity using clinical and biological specimens was also successful.
format Online
Article
Text
id pubmed-7113781
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Authors. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71137812020-04-02 Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens Mo, Jongseo Angelichio, Michael Gow, Lisa Leathers, Valerie Jackwood, Mark W. J Virol Methods Article Infectious bronchitis (IB) is a highly contagious upper respiratory tract disease of chickens caused by infectious bronchitis virus (IBV), which has various serotypes that do not cross-protect. Vaccine control strategies for this virus are only effective when designed around the currently circulating serotypes. It is essential to not only rapidly detect IBV but also to identify the type of virus causing disease. Six TaqMan™-based quantitative real-time RT-PCR assays (Universal, Ark, Mass, DE/GA98, GA07, GA08) were developed and examined the sensitivity and specificity for each assay. Assays were developed targeting the hypervariable region in the S1 gene subunit. The analytical sensitivity of TaqMan™-based quantitative real-time RT-PCR assays (qRT-PCR) assays was evaluated using synthetic DNA standards that were identical with the target sequence and specificity was further validated using clinical and biological specimens. All developed assays performed equivalently when using synthetic DNA templates as standard material, as it achieved linearity over a 5 log(10) dynamic range with a reproducible limit of detection of ≤10 target copies per reaction, with high calculated amplification efficiencies ranging between 90%–115%. Further validation of specificity using clinical and biological specimens was also successful. The Authors. Published by Elsevier B.V. 2020-02 2019-11-08 /pmc/articles/PMC7113781/ /pubmed/31712094 http://dx.doi.org/10.1016/j.jviromet.2019.113773 Text en © 2019 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Mo, Jongseo
Angelichio, Michael
Gow, Lisa
Leathers, Valerie
Jackwood, Mark W.
Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens
title Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens
title_full Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens
title_fullStr Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens
title_full_unstemmed Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens
title_short Validation of specific quantitative real-time RT-PCR assay panel for Infectious Bronchitis using synthetic DNA standards and clinical specimens
title_sort validation of specific quantitative real-time rt-pcr assay panel for infectious bronchitis using synthetic dna standards and clinical specimens
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113781/
https://www.ncbi.nlm.nih.gov/pubmed/31712094
http://dx.doi.org/10.1016/j.jviromet.2019.113773
work_keys_str_mv AT mojongseo validationofspecificquantitativerealtimertpcrassaypanelforinfectiousbronchitisusingsyntheticdnastandardsandclinicalspecimens
AT angelichiomichael validationofspecificquantitativerealtimertpcrassaypanelforinfectiousbronchitisusingsyntheticdnastandardsandclinicalspecimens
AT gowlisa validationofspecificquantitativerealtimertpcrassaypanelforinfectiousbronchitisusingsyntheticdnastandardsandclinicalspecimens
AT leathersvalerie validationofspecificquantitativerealtimertpcrassaypanelforinfectiousbronchitisusingsyntheticdnastandardsandclinicalspecimens
AT jackwoodmarkw validationofspecificquantitativerealtimertpcrassaypanelforinfectiousbronchitisusingsyntheticdnastandardsandclinicalspecimens